+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Alternative & Complementary Medicine Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5313768
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Alternative & Complementary Medicine Market is projected to reach USD 244.22 Billion in 2026. It is expected to continue growing at a CAGR of 13.33%, reaching USD 518.80 Billion by 2032.

Alternative and complementary medicine is moving from a wellness-adjacent category into a more formal part of preventive health, chronic disease support, pain management, rehabilitation, and mental well-being strategies. Demand is supported by aging populations, rising noncommunicable disease burden, consumer preference for holistic care, and broader acceptance of practices such as acupuncture, chiropractic care, Ayurveda, herbal medicine, naturopathy, meditation, yoga, massage therapy, osteopathy, and traditional Chinese medicine.

The World Health Organization reports that traditional, complementary, and integrative medicine is used in most countries, with many governments developing national policies, practitioner standards, research frameworks, and herbal medicine regulations. For industry leaders, the opportunity is no longer limited to consumer products; it increasingly includes evidence generation, clinical integration, digital delivery, quality assurance, pharmacovigilance, and culturally relevant care models.

Transformative Shifts in the Alternative & Complementary Medicine Landscape

The landscape is being reshaped by evidence-based wellness, patient-centered care, and the convergence of conventional medicine with complementary therapies. Health systems are selectively integrating acupuncture, mindfulness, yoga, chiropractic care, osteopathy, and massage where clinical evidence supports use, particularly for pain, stress, sleep, rehabilitation, musculoskeletal conditions, and quality-of-life improvement.

At the same time, regulators are tightening expectations for product safety, labeling, practitioner credentials, advertising claims, and claims substantiation. This is creating a shift away from fragmented, informal markets toward professionalized services, standardized herbal formulations, transparent sourcing, validated manufacturing practices, and outcome-based partnerships with clinics, insurers, employers, pharmacies, and digital health platforms.

Cumulative Impact of Artificial Intelligence on Complementary Health

Artificial intelligence is becoming a cumulative force across alternative and complementary medicine by improving personalization, evidence discovery, supply chain traceability, quality control, and consumer engagement. AI tools can support symptom triage, lifestyle coaching, treatment adherence, digital therapeutics, practitioner workflows, and pattern recognition across patient-reported outcomes, wearable data, and electronic health records when deployed under appropriate clinical governance.

The greatest impact is emerging in areas that require scale and consistency, including herbal ingredient authentication, contamination screening, adverse event monitoring, practitioner matching, virtual wellness programs, research synthesis, and multilingual consumer education. However, AI adoption must be paired with data privacy, bias mitigation, explainability, clinical validation, human oversight, and clear boundaries between wellness guidance and regulated medical advice.

Key Regional Insights Across Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

Asia-Pacific remains a foundational region because China, India, Japan, South Korea, Australia, and ASEAN markets combine long-standing medical traditions with expanding digital health infrastructure and formal policy recognition. Traditional Chinese medicine, Ayurveda, Kampo, yoga, acupuncture, herbal products, and mind-body therapies benefit from cultural acceptance, public-sector integration in selected health systems, practitioner education pathways, and export-oriented manufacturing capabilities.

North America is driven by consumer adoption of integrative health, chronic pain management, mental wellness, healthy aging, and employer wellness programs, with the United States and Canada emphasizing evidence, safety, professional credentials, and natural health product oversight. Europe shows structured demand through integrative clinics, pharmacy channels, natural products, osteopathy, homeopathy in selected settings, and strong regulation covering quality, labeling, and safety. Latin America is supported by indigenous and community herbal medicine traditions, expanding private healthcare, and wellness retail, while the Middle East is advancing through premium wellness clinics, preventive health initiatives, medical tourism, and hospitality-linked wellness services. Africa continues to reflect high reliance on traditional medicine in many communities, with growing attention to formal practitioner recognition, botanical quality standards, research capacity, and safe integration with primary healthcare.

Key Group Insights for ASEAN, GCC, European Union, BRICS, G7, and NATO Markets

ASEAN markets are gaining relevance through herbal products, wellness tourism, traditional therapies, digital commerce, and rising middle-class health expenditure, while the GCC is expanding premium wellness clinics, preventive health programs, longevity services, and medical tourism assets aligned with national health transformation agendas. The European Union is shaped by strict product quality, safety documentation, advertising standards, and cross-border regulatory harmonization, which favors organizations with disciplined compliance systems and validated supply chains.

BRICS economies provide scale through large populations, established traditional medicine systems, domestic manufacturing, medicinal plant resources, and growing digital health and e-commerce adoption. G7 markets are attractive for clinically validated services, premium supplements, practitioner-led integrative care, and insurer or employer-linked wellness models that require strong evidence and governance. NATO economies overlap with several high-income healthcare markets where supply chain resilience, cybersecurity, trusted health data infrastructure, and regulatory alignment increasingly influence strategic partnerships in complementary and integrative medicine.

Key Country Insights for Leading Alternative & Complementary Medicine Markets

The United States leads in consumer adoption of complementary health approaches, with National Health Interview Survey data showing broad adult use of yoga, meditation, chiropractic care, massage therapy, naturopathy, and acupuncture. Canada emphasizes regulated natural health products, professional oversight in several provinces, and strong consumer interest in preventive wellness, while Mexico and Brazil combine traditional herbal practices, community-based healing, expanding wellness retail, and private healthcare demand.

In Europe, the United Kingdom, Germany, France, Italy, and Spain support strong demand for natural products, osteopathy, acupuncture, homeopathy in selected channels, herbal medicine, and integrative wellness, while Russia has a sizable herbal and traditional treatment base supported by consumer familiarity with phytotherapy and sanatorium-style wellness traditions. China and India are central to global supply, practice, and knowledge systems through traditional Chinese medicine and Ayurveda, supported by formal education, policy frameworks, and export activity. Japan, Australia, and South Korea add mature consumer markets, high quality expectations, and growing interest in preventive, digital, musculoskeletal, beauty-from-within, stress management, and aging-related care.

Actionable Recommendations for Alternative & Complementary Medicine Leaders

Industry leaders should prioritize evidence-backed differentiation, transparent sourcing, responsible clinical communication, and compliant health claims to build trust with patients, clinicians, regulators, retailers, and digital platforms. Organizations should invest in clinical studies, real-world evidence, safety surveillance, adverse event reporting, practitioner education, and standardized protocols for therapies used in pain, stress, sleep, musculoskeletal health, digestive wellness, immune support, women’s health, and healthy aging.

Strategically, organizations should develop omnichannel models that combine clinics, pharmacies, e-commerce, telehealth, mobile apps, and subscription-based wellness programs. Partnerships with hospitals, insurers, employers, universities, accredited practitioner networks, and quality-certified suppliers can improve credibility and access. Leaders should also adopt AI responsibly, strengthen cybersecurity, verify botanical supply chains, monitor contaminants and adulterants, and localize offerings to regional medical traditions, language preferences, cultural expectations, and regulatory frameworks.

Research Methodology Based on Verified Public Health and Market Intelligence

This executive summary is developed using a structured secondary research methodology that prioritizes validated public health, regulatory, clinical, and market intelligence sources. Key references include data and guidance from the World Health Organization, national health agencies, peer-reviewed journals, regulatory authorities, professional associations, pharmacopoeias, and government datasets covering traditional medicine, complementary health use, product safety, practitioner regulation, and healthcare utilization.

The analysis applies triangulation across policy developments, consumer behavior indicators, practitioner regulation, clinical evidence, digital health adoption, regional healthcare priorities, and supply chain dynamics.

Conclusion: Credibility, Evidence, and Integration Define the Future

Alternative and complementary medicine is entering a new phase defined by professionalization, evidence generation, digital enablement, quality assurance, and selective integration with mainstream healthcare. Momentum is strongest where consumer demand aligns with regulatory clarity, practitioner standards, trusted products, transparent sourcing, and measurable outcomes.

The next competitive advantage will come from credibility rather than claims volume. Organizations that combine traditional knowledge with scientific validation, responsible AI, compliant communications, safe products, and culturally relevant care models will be best positioned to address demand across preventive health, chronic care support, mental wellness, healthy aging, pain management, and integrative medicine.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Alternative & Complementary Medicine Market, by Therapy Type
7.1. Introduction
7.2. Biologically Based Therapies
7.2.1. Aromatherapy
7.2.2. Botanical Medicine
7.2.3. Dietary Supplements
7.2.4. Functional Food & Nutraceuticals
7.3. Energy therapies
7.3.1. Acupuncture
7.3.2. Healing touch
7.3.3. Magnet therapy
7.3.4. Reiki
7.4. Manipulative & Body-Based Methods
7.4.1. Chiropractic Therapy
7.4.2. Cupping
7.4.3. Massage Therapy
7.4.4. Osteopathic Manipulation
7.4.5. Reflexology
7.5. Mind-Body Medicine
7.5.1. Hypnotherapy (hypnosis)
7.5.2. Meditation
7.5.3. Relaxation Techniques
7.6. Traditional Alternative Medicine Systems
7.6.1. Ayurveda
7.6.2. Homeopathy
7.6.3. Naturopathy
7.6.4. Traditional Chinese medicine
8. Alternative & Complementary Medicine Market, by Disease Indication
8.1. Introduction
8.2. Cancer Support & Palliative Care
8.3. Cardiovascular Health
8.4. Diabetes Management
8.5. Gastrointestinal Issues
8.6. Insomnia & Sleep Disorders
8.7. Mental Health & Depression
8.8. Pain Management
8.9. Respiratory Disorders
8.10. Skin & Hair Disorders
8.11. Stress & Anxiety Disorders
9. Alternative & Complementary Medicine Market, by End-User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Home Care Settings
9.4. Hospitals & Specialty Clinics
9.5. Individual Practitioners
9.6. Wellness Centers & Spas
10. Alternative & Complementary Medicine Market, by Distribution Channel
10.1. Introduction
10.2. E-commerce
10.3. Offline Retail
10.3.1. Health & Wellness Retail Stores
10.3.2. Pharmacies & Drug Stores
11. Alternative & Complementary Medicine Market, by Region
11.1. Asia-Pacific
11.2. Europe
11.3. North America
11.4. Latin America
11.5. Africa
11.6. Middle East
12. Alternative & Complementary Medicine Market, by Group
12.1. NATO
12.2. G7
12.3. European Union
12.4. BRICS
12.5. ASEAN
12.6. GCC
13. Alternative & Complementary Medicine Market, by Country
13.1. United States
13.2. China
13.3. Germany
13.4. Japan
13.5. India
13.6. United Kingdom
13.7. France
13.8. Canada
13.9. Italy
13.10. Australia
13.11. South Korea
13.12. Brazil
13.13. Mexico
13.14. Russia
13.15. Spain
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. AmeriCare Physical Therapy by Ivy Rehab
15.2. AYUSH Ayurvedic Pte Ltd.
15.3. Baidyanath Group
15.4. Boiron Laboratories
15.5. Dabur India Ltd.
15.6. Dr. Willmar Schwabe India Pvt. Ltd.
15.7. Emami Limited
15.8. First Natural Brands Ltd.
15.9. Full Motion Physical Therapy
15.10. Gaia Herbs, Inc.
15.11. Hamdard Laboratories
15.12. Herb Pharm, LLC
15.13. Kerala Ayurveda Ltd.
15.14. Mountain Rose Herbs
15.15. Nature's Bounty, Inc. by Nestlé Health Science
15.16. Nelson & Co Ltd.
15.17. Nordic Naturals
15.18. Patanjali Ayurved Ltd.
15.19. PEKANA Naturheilmittel GmbH
15.20. Pharmesis International Ltd.
15.21. Rocky Mountain Oils LLC
15.22. SBL Pvt. Ltd.
15.23. Seirin Corporation
15.24. Sheng Chang Pharmaceutical Company
15.25. The Arya Vaidya Pharmacy (CBE) Ltd.
15.26. The Himalaya Drug Company
15.27. Tsumura & Co.
15.28. Vicco Laboratories
15.29. Wen Ken Group
List of Figures
FIGURE 1. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICALLY BASED THERAPIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICALLY BASED THERAPIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL BIOLOGICALLY BASED THERAPIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL AROMATHERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL AROMATHERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL AROMATHERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL BOTANICAL MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL BOTANICAL MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL BOTANICAL MEDICINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL DIETARY SUPPLEMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL DIETARY SUPPLEMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL DIETARY SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL FUNCTIONAL FOOD & NUTRACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL FUNCTIONAL FOOD & NUTRACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL FUNCTIONAL FOOD & NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL ENERGY THERAPIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL ENERGY THERAPIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL ENERGY THERAPIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL ACUPUNCTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL ACUPUNCTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL ACUPUNCTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL HEALING TOUCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL HEALING TOUCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL HEALING TOUCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL MAGNET THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL MAGNET THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL MAGNET THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL REIKI MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL REIKI MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL REIKI MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL MANIPULATIVE & BODY-BASED METHODS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL MANIPULATIVE & BODY-BASED METHODS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL MANIPULATIVE & BODY-BASED METHODS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL CHIROPRACTIC THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL CHIROPRACTIC THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL CHIROPRACTIC THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL CUPPING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL CUPPING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CUPPING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL MASSAGE THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL MASSAGE THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL MASSAGE THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL OSTEOPATHIC MANIPULATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL OSTEOPATHIC MANIPULATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL OSTEOPATHIC MANIPULATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL REFLEXOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL REFLEXOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL REFLEXOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL MIND-BODY MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL MIND-BODY MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL MIND-BODY MEDICINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL HYPNOTHERAPY (HYPNOSIS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL HYPNOTHERAPY (HYPNOSIS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL HYPNOTHERAPY (HYPNOSIS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL MEDITATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL MEDITATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL MEDITATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL RELAXATION TECHNIQUES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL RELAXATION TECHNIQUES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL RELAXATION TECHNIQUES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL AYURVEDA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL AYURVEDA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL AYURVEDA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL HOMEOPATHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL HOMEOPATHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL HOMEOPATHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL NATUROPATHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL NATUROPATHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL NATUROPATHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL TRADITIONAL CHINESE MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL TRADITIONAL CHINESE MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL TRADITIONAL CHINESE MEDICINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL CANCER SUPPORT & PALLIATIVE CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL CANCER SUPPORT & PALLIATIVE CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL CANCER SUPPORT & PALLIATIVE CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL CARDIOVASCULAR HEALTH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL CARDIOVASCULAR HEALTH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL CARDIOVASCULAR HEALTH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL GASTROINTESTINAL ISSUES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL GASTROINTESTINAL ISSUES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL GASTROINTESTINAL ISSUES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL INSOMNIA & SLEEP DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL INSOMNIA & SLEEP DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL INSOMNIA & SLEEP DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL MENTAL HEALTH & DEPRESSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL MENTAL HEALTH & DEPRESSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL MENTAL HEALTH & DEPRESSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL SKIN & HAIR DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL SKIN & HAIR DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL SKIN & HAIR DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL STRESS & ANXIETY DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL STRESS & ANXIETY DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL STRESS & ANXIETY DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL HOSPITALS & SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL HOSPITALS & SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL HOSPITALS & SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL INDIVIDUAL PRACTITIONERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL INDIVIDUAL PRACTITIONERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL INDIVIDUAL PRACTITIONERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL WELLNESS CENTERS & SPAS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL WELLNESS CENTERS & SPAS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL WELLNESS CENTERS & SPAS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL E-COMMERCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL E-COMMERCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL E-COMMERCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL OFFLINE RETAIL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL OFFLINE RETAIL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL OFFLINE RETAIL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL HEALTH & WELLNESS RETAIL STORES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL HEALTH & WELLNESS RETAIL STORES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL HEALTH & WELLNESS RETAIL STORES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL PHARMACIES & DRUG STORES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL PHARMACIES & DRUG STORES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL PHARMACIES & DRUG STORES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2017-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2017-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2017-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2017-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2017-2032 (USD MILLION)
TABLE 151. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 152. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 153. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2017-2032 (USD MILLION)
TABLE 154. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2017-2032 (USD MILLION)
TABLE 155. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2017-2032 (USD MILLION)
TABLE 156. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2017-2032 (USD MILLION)
TABLE 157. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 158. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 159. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 160. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 161. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2017-2032 (USD MILLION)
TABLE 162. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 163. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 164. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2017-2032 (USD MILLION)
TABLE 165. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2017-2032 (USD MILLION)
TABLE 166. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2017-2032 (USD MILLION)
TABLE 167. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2017-2032 (USD MILLION)
TABLE 168. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 169. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 170. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 171. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 172. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2017-2032 (USD MILLION)
TABLE 173. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 174. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 175. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2017-2032 (USD MILLION)
TABLE 176. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2017-2032 (USD MILLION)
TABLE 177. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2017-2032 (USD MILLION)
TABLE 178. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2017-2032 (USD MILLION)
TABLE 179. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 180. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 181. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 182. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 183. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2017-2032 (USD MILLION)
TABLE 184. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 185. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 186. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2017-2032 (USD MILLION)
TABLE 187. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2017-2032 (USD MILLION)
TABLE 188. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2017-2032 (USD MILLION)
TABLE 189. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2017-2032 (USD MILLION)
TABLE 190. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 191. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 192. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 193. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 194. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2017-2032 (USD MILLION)
TABLE 195. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 196. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 197. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2017-2032 (USD MILLION)
TABLE 198. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2017-2032 (USD MILLION)
TABLE 199. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2017-2032 (USD MILLION)
TABLE 200. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2017-2032 (USD MILLION)
TABLE 201. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 202. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 203. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 204. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 205. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2017-2032 (USD MILLION)
TABLE 206. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 207. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 208. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 209. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2017-2032 (USD MILLION)
TABLE 210. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2017-2032 (USD MILLION)
TABLE 211. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2017-2032 (USD MILLION)
TABLE 212. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2017-2032 (USD MILLION)
TABLE 213. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 214. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 215. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 216. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 217. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2017-2032 (USD MILLION)
TABLE 218. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 219. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 220. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2017-2032 (USD MILLION)
TABLE 221. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2017-2032 (USD MILLION)
TABLE 222. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2017-2032 (USD MILLION)
TABLE 223. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2017-2032 (USD MILLION)
TABLE 224. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 225. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 226. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 227. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 228. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2017-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2017-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2017-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2017-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2017-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2017-2032 (USD MILLION)
TABLE 240. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 241. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 242. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2017-2032 (USD MILLION)
TABLE 243. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2017-2032 (USD MILLION)
TABLE 244. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2017-2032 (USD MILLION)
TABLE 245. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2017-2032 (USD MILLION)
TABLE 246. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 247. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 248. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 249. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 250. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2017-2032 (USD MILLION)
TABLE 251. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 252. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 253. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2017-2032 (USD MILLION)
TABLE 254. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2017-2032 (USD MILLION)
TABLE 255. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2017-2032 (USD MILLION)
TABLE 256. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2017-2032 (USD MILLION)
TABLE 257. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 258. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 259. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 260. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 261. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2017-2032 (USD MILLION)
TABLE 262. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 263. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 264. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2017-2032 (USD MILLION)
TABLE 265. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2017-2032 (USD MILLION)
TABLE 266. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2017-2032 (USD MILLION)
TABLE 267. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2017-2032 (USD MILLION)
TABLE 268. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 269. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 270. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 271. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 272. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2017-2032 (USD MILLION)
TABLE 273. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 274. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 275. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 276. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2017-2032 (USD MILLION)
TABLE 277. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2017-2032 (USD MILLION)
TABLE 278. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2017-2032 (USD MILLION)
TABLE 279. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2017-2032 (USD MILLION)
TABLE 280. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 281. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 282. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 283. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 284. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2017-2032 (USD MILLION)
TABLE 285. CHINA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 286. CHINA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 287. CHINA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2017-2032 (USD MILLION)
TABLE 288. CHINA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2017-2032 (USD MILLION)
TABLE 289. CHINA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2017-2032 (USD MILLION)
TABLE 290. CHINA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2017-2032 (USD MILLION)
TABLE 291. CHINA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 292. CHINA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 293. CHINA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 294. CHINA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 295. CHINA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2017-2032 (USD MILLION)
TABLE 296. GERMANY ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 297. GERMANY ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 298. GERMANY ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2017-2032 (USD MILLION)
TABLE 299. GERMANY ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2017-2032 (USD MILLION)
TABLE 300. GERMANY ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2017-2032 (USD MILLION)
TABLE 301. GERMANY ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2017-2032 (USD MILLION)
TABLE 302. GERMANY ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 303. GERMANY ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 304. GERMANY ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 305. GERMANY ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 306. GERMANY ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2017-2032 (USD MILLION)
TABLE 307. JAPAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 308. JAPAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 309. JAPAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2017-2032 (USD MILLION)
TABLE 310. JAPAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2017-2032 (USD MILLION)
TABLE 311. JAPAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2017-2032 (USD MILLION)
TABLE 312. JAPAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2017-2032 (USD MILLION)
TABLE 313. JAPAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 314. JAPAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 315. JAPAN ALTERNATIVE & COMPLEMENTARY MED

Companies Mentioned

  • AmeriCare Physical Therapy by Ivy Rehab
  • AYUSH Ayurvedic Pte Ltd.
  • Baidyanath Group
  • Boiron Laboratories
  • Dabur India Ltd.
  • Dr. Willmar Schwabe India Pvt. Ltd.
  • Emami Limited
  • First Natural Brands Ltd.
  • Full Motion Physical Therapy
  • Gaia Herbs, Inc.
  • Hamdard Laboratories
  • Herb Pharm, LLC
  • Kerala Ayurveda Ltd.
  • Mountain Rose Herbs
  • Nature's Bounty, Inc. by Nestlé Health Science
  • Nelson & Co Ltd.
  • Nordic Naturals
  • Patanjali Ayurved Ltd.
  • PEKANA Naturheilmittel GmbH
  • Pharmesis International Ltd.
  • Rocky Mountain Oils LLC
  • SBL Pvt. Ltd.
  • Seirin Corporation
  • Sheng Chang Pharmaceutical Company
  • The Arya Vaidya Pharmacy (CBE) Ltd.
  • The Himalaya Drug Company
  • Tsumura & Co.
  • Vicco Laboratories
  • Wen Ken Group

Table Information